After reporting a third-quarter earnings and sales miss May 1, Clorox Co (NYSE: CLX) has been downgraded by a notable analyst.
Argus analyst John Staszak downgraded Clorox from Buy to Hold.
After seeing 4-percent sales growth in the first and second quarters, Clorox posted just 2 percent growth in the third quarter, reflecting increased competition in the bags, wraps and wipes categories, Staszak said in the Friday downgrade note. (See his track record here.)
Clorox reduced its near-term revenue growth target from 2-4 percent to 2-3 percent. The analyst said he expects Clorox earnings to face pressure from increased promotional spending.
“The shares are currently trading at 23.2-times our revised FY19 earnings estimate, which we think adequately reflects prospects for less rapid growth."
Argus lowered its 2019 EPS estimate from $6.60 to $6.36 and its 2020 estimate from $7 to $6.70.
Clorox’s cleaning and household segments both saw a 1-percent year-over-year sales decrease in the third quarter, Staszak said. The company’s lifestyle segment saw a 23-percent year-over-year increase, but was still $5 million below consensus estimates, he said.
For investors interested in the consumer staples sector, the analyst said he recommends Buy-rated Estee Lauder Companies (NYSE: EL).
Clorox shares were down 0.22 percent at $146.72 at the close Monday.
A Few Key Takeaways From Clorox's Analyst Presentation
Pro: Consumer Goods Stocks Surging In 'Clear Change' In Market Leadership
Latest Ratings for CLX
|May 2019||Maintains||Market Perform||Market Perform|
View More Analyst Ratings for CLX
View the Latest Analyst Ratings
See more from Benzinga
- Stifel: Amid Low Expectations, Jack In The Box Is Now A Buy
- Morgan Stanley Downgrades Michaels, Cites Lack Of Catalysts
- Zion Williamson's Marketability Takes A Big Hit If He Lands With The Pelicans
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.